Fares Badr Jammal

Dr. Fares Badr Jammal

Computer science, King Abdulaziz University, Jeddah, Makkah al Mukarramah, Saudi Arabia
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
FJFares Badr Jammal
Fares Badr Jammal
MDMohamed Yehia Dahab
Mohamed Yehia Dahab
ABareej bayahya
areej bayahya
Background/Objectives: Acute Lymphoblastic Leukemia (ALL) poses significant diagnostic challenges due to its ambiguous symptoms and the limitations of conventional methods like bone marrow biopsies and flow cytometry, which are invasive, costly, and time-intensive. Methods: This study introduces Neuro-Bridge-X, a novel neuro-symbolic hybrid model designed for automated, explainable ALL diagnosis using peripheral blood smear (PBS) images. Leveraging two comprehensive datasets, ALL Image (3256 images from 89 patients) and C-NMC (15,135 images from 118 patients), the model integrates deep morphological feature extraction, vision transformer-based contextual encoding, fuzzy logic-inspired reasoning, and adaptive explainability. To address class imbalance, advanced data augmentation techniques were applied, ensuring equitable representation across benign and leukemic classes. The proposed framework was evaluated through 5-fold cross-validation and fixed train-test splits, employing Nadam, SGD, and Fractional RAdam optimizers. Results: Results demonstrate exceptional performance, with SGD achieving near-perfect accuracy (1.0000 on ALL, 0.9715 on C-NMC) and robust generalization, while Fractional RAdam closely followed (0.9975 on ALL, 0.9656 on C-NMC). Nadam, however, exhibited inconsistent convergence, particularly on C-NMC (0.5002 accuracy). A Meta-XAI controller enhances interpretability by dynamically selecting optimal explanation strategies (Grad-CAM, SHAP, Integrated Gradients, LIME), ensuring clinically relevant insights into model decisions. Conclusions: Visualizations confirm that SGD and RAdam models focus on morphologically critical features, such as leukocyte nuclei, while Nadam struggles with spurious attributions. Neuro-Bridge-X offers a scalable, interpretable solution for ALL diagnosis, with potential to enhance clinical workflows and diagnostic precision in oncology.

13 October 2025 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
PDF file
FJFares Badr Jammal
Fares Badr Jammal
MDMohamed Dahab
Mohamed Dahab
Acute Lymphoblastic Leukemia (ALL) is a prevalent malignancy particularly among children. It poses diagnostic challenges due to its morphological similarities with normal cells and the limitations of conventional methods like bone marrow biopsies, which are invasive and resource-intensive. This study introduces Causal-Former-HMC, a novel hybrid AI architecture integrating convolutional neural networks, vision transformers, and a causal graph learner with counterfactual reasoning to enhance diagnostic precision and interpretability from peripheral blood smear (PBS) images. We utilized two robust datasets: the ALL Image collection, comprising 89 patients and 3,256 PBS images (504 benign, 2,752 malignant across Pro B, Pre B, and Early Pre B subtypes), and C-NMC dataset, containing 15,135 segmented cell images from 118 patients (7,272 leukemic, 3,389 normal). To address class imbalance, we implemented class-aware data augmentation, standardizing image counts across classes and resizing to 128 × 128 pixels for compatibility with our model. The proposed model is evaluated via stratified 5-fold cross-validation with Nadam, SGD, and Radam (fractional) optimizers, Causal-Former-HMC achieved perfect classification accuracy (100%) and macro-averaged F1-scores on the ALL dataset, and up to 98.5% accuracy with 0.9975 ROC-AUC on the C-NMC dataset hence demonstrating superior generalization. Interpretability was ensured through advanced explainable AI techniques, including Grad-CAM, LIME, Integrated Gradients, and SHAP, which consistently highlighted attention to clinically relevant features such as nuclear contour irregularities and chromatin condensation. These results underscore the potential of the model to deliver non-invasive, accurate and transparent diagnostics that pave the way for its integration into clinical hematology workflows and advancing AI-driven leukemia screening paradigms. Index Terms—Acute Lymphoblastic Leukemia (ALL); Causal-Former-HMC; Hybrid Deep Learning; Peripheral Blood Smear Classification; Explainable AI in Medical Imaging.

29 March 2023 in Electronics
Verified
Journal Article
Open access
PDF file
FJFares Badr Jammal
Fares Badr Jammal
NANaif Aljabri
Naif Aljabri
MAMohammed AL-Hashimi
Mohammed AL-Hashimi
MSMostafah Elsayed Saleh
Mostafah Elsayed Saleh
Osama A. AbulnajaOsama A. Abulnaja
Osama A. Abulnaja
Matrix multiplication is ubiquitous in high-performance applications. It will be a significant part of exascale workloads where power is a big concern. This work experimentally studied the power efficiency of three matrix multiplication algorithms: the definition-based, Strassen’s divide-and-conquer, and an optimized divide-and-conquer. The study used reliable on-chip integrated voltage regulators for measuring the power. Interactions with memory, mainly cache misses, were thoroughly investigated. The main result was that the optimized divide-and-conquer algorithm, which is the most time-efficient, was also the most power-efficient, but only for cases that fit in the cache. It consumed drastically less overall energy than the other two methods, regardless of placement in memory. For matrix sizes that caused a spill to the main memory, the definition-based algorithm consumes less power than the divide-and-conquer ones at a high total energy cost. The findings from this study may be of interest when cutting power usage is more vital than running for the shortest possible time or least amount of energy.

3 June 2026 in Scientific Reports
Verified
Journal Article
Open access
FJFares Badr Jammal
Fares Badr Jammal
Acute Lymphoblastic Leukemia (ALL) is one of the most aggressive hematological malignancies, and its early diagnosis remains challenging due to non-specific clinical symptoms and reliance on invasive procedures such as bone marrow biopsies. To address these limitations, we propose Meta-Conformer-XAI, a novel meta-learned hybrid deep learning framework for non-invasive ALL detection using microscopic peripheral blood smear images. Unlike conventional CNN-Transformer pipelines, our approach integrates three key innovations: (1) a Dual Attention Feature Fusion (DAFF) block that adaptively combines local morphological features extracted by a CNN with global contextual dependencies captured by a Vision Transformer (ViT); (2) a Meta-Learning Path Controller, which dynamically optimizes information flow between convolutional and transformer pathways for improved generalization across heterogeneous datasets; and (3) a Reinforcement Learning-based Confidence Estimator, ensuring robust decision reliability in clinical settings. We validated the framework on two benchmark datasets, the ALL Image Dataset and the C-NMC Leukemia Dataset using both fixed train/validation/test splits and 5-fold cross-validation. To mitigate class imbalance, a class-aware augmentation strategy was employed, significantly improving minority-class recognition. Meta-Conformer-XAI achieved 0.9924 accuracy on the ALL dataset and 0.9636 accuracy on the C-NMC dataset, with AUC-ROC scores exceeding 0.99 across both, outperforming baseline CNNs, ViTs, and existing hybrid architectures. Furthermore, the framework incorporates a comprehensive explainability module combining Grad-CAM, SHAP, LIME, and Integrated Gradients, providing transparent insights into feature attribution and clinical relevance. Overall, Meta-Conformer-XAI advances the state of the art in automated leukemia diagnosis by offering a precise, interpretable, and scalable tool that addresses current limitations of diagnostic invasiveness, model generalization, and clinical trustworthiness.

13 September 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
FJFares Badr Jammal
Fares Badr Jammal
The handling of acute lymphoblastic leukemia (ALL) which is the most common malignancy in children, depends on a prompt and precise diagnosis. Conventional techniques, such as bone marrow aspiration followed by flow cytometry, provide reliable results but have serious limitations. These include being invasive, requiring skilled handling, consuming valuable time, and occasionally yielding unclear readings. We present ConfuNetHMA, a novel automated diagnostic tool that analyses peripheral blood smear pictures in order to get over these obstacles. Fundamentally, our approach combines two complementing deep learning architectures: vision transformers to understand broad correlations throughout the entire slide, and convolutional neural networks to capture fine-grained, localized patterns in individual cells. By combining local and global information into a single, coherent picture, these elements communicate via a layered “meta-attention” mechanism. A lightweight meta-learning-inspired module produces an optimiser-selection policy conditioned on the fused feature representation; in this work it is used to identify and recommend the best-performing optimiser per dataset across runs. To confirm its robustness, ConfuNet-HMA was tested both on a fixed train/validation/test split and via five-fold cross-validation. The model reaches 100% classification accuracy on ALL dataset and 97.39% accuracy on C-NMC dataset and maintains an ROC-AUC of 0.994 in differentiating ALL subtypes, with uniformly high precision and recall across categories. Recognizing that clinicians need to trust AI decisions, we’ve integrated several explainability tools. Grad-CAM highlights which regions of each cell influenced the diagnosis, while LIME, SHAP, and Integrated Gradients offer complementary views into feature importance pinpointing nuclear shapes, chromatin textures, and cytoplasmic details that pathologists routinely examine. Because these highlighted features align with established haematological criteria, practitioners can follow the AI’s “thought process” rather than treating it as an inscrutable black box.